Anti-LCMV Nucleoprotein — Purified No Carrier Protein (Clone VL-4)
Roll over image to zoom in
Shipping Info:
For estimated delivery dates, please contact us at [email protected]
| Format : | Purified |
| Amount : | 1 mg |
| Isotype : | Rat IgG2a κ |
| Purification : | Purity: ≥90% monomer by analytical SEC and SDS-Page |
| Content : | Product Concentration ≥1.0 mg/ml Formulation: This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. |
| Storage condition : | This antibody may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. |
| Alternative Name : | Protein N, LCMV Nucleocapsid Protein |
| Immunogen Information : | Lymphocytic choriomeningitis virus (LCMV) |
Specificity
VL-4 activity is directed against LCMV nucleoprotein, staining LCMV-infected cells internally.
VL-4 does not react with influenza-, vaccinia-, or vesicular stomatitis-infected cells.
VL-4 does not react with influenza-, vaccinia-, or vesicular stomatitis-infected cells.
Background
Lymphocytic choriomeningitis virus (LCMV) is a neglected human pathogenic arenavirus with worldwide distribution. Arenaviruses cause human infection through mucosal exposure to aerosols or by direct contact with abraded skin of infected rodents 1. LCMV infection may carry health risks for humans who are immunocompromised or pregnant.
Research Use Only
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
|
There are currently no product reviews
|
.png "ACE2/HEK293 Stable Cell Line")
